周口哪里有算生辰八字的安图算命哪里准,福州寺庙哪里可以算命,绍兴哪有算命的地方,罗甸哪里算卦算的好,承德算命一条街哪家准,嘉兴哪里算命算卦准灵验,汝阳哪里算卦比较准

LOS ANGELES, April 4 (Xinhua) -- A woman's breast milk cells may be used to predict cancer in future research, according to a study published by HealthDay News on Monday.In the study, researchers at the University of Massachusetts in Amherst collected breast milk from 271 women in the United States. All had either undergone a biopsy of the breast to check for cancer, or were scheduled for one.The researchers evaluated breast milk samples from the biopsied and non-biopsied breasts.The researchers first isolated potentially cancerous cells, known as epithelial cells, and then isolated DNA to look for signals that regulate tumor suppresser genes.In the next step, the researchers analyzed three genes among the many known to undergo a process called methylation in breast cancer. Methylation in a specific region of a gene can inhibit or suppress the expression of a gene.For one gene, SFRP1, the average methylation was higher in the biopsied breast, the study found.Among the women whose biopsies detected cancer, average methylation of the RASSF1 gene in the biopsied breast was considerably higher compared to the non-biopsied breast.Among the women whose biopsies detected cancer, average methylation of the RASSF1 gene in the biopsied breast was considerably higher compared to the non-biopsied breast."It looks as if we can use the cells from breast milk to assess breast cancer risk," said Dr. Kathleen Arcaro, an associate professor of veterinary and animal sciences at the university.It's too soon, however, to assess the cancer detection rate associated with breast milk cell examination, she said."We can't say at this point for two reasons," she said. "One is, we need long-term follow-up. And the second really important reason is, we need to sample a larger panel of genes."Arcaro is to present her findings later Monday at the annual meeting of the American Association for Cancer Research in Orlando, Florida, according to HealthDay News.

HARBIN, March 2 (Xinhua) -- A therapeutic apparatus to treat Parkinson's disease has been developed in northeast China's Heilongjiang Province, according to the provincial science and technology department. It is a worldwide breakthrough in treating the disease with transcranial magnetic stimulation, concluded an expert panel with the Heilongjiang Provincial Department of Science and Technology.The team said it came to the conclusion after evaluating technical documents and clinical test results Monday.This is the first time that transcranial magnetic stimulation has been adopted to treat Parkinson's disease, said Sun Zuodong, chairman of Aobo Medicine Apparatus Co., Ltd. (AMA), the developer based in the provincial capital Harbin.Transcranial magnetic stimulation is a noninvasive method which causes depolarization in the brains' neurons so as to restore the functions of brain nerves.The apparatus consists of three parts, namely brain wave stimulator, field effect cap and multiplier, said Sun.Clinical tests over more than 100 patients showed that the apparatus had a 70 percent success rate in reducing the disease's symptoms, according to Wang Aili, planning manager of AMA.The new equipment will help generation of dopamine, the reduction of which within the brain caused the disease, said Wang Weixiang, a consulting doctor with the Heilongjiang Provincial Rehabilitation Hospital.Parkinson's disease is a disorder of the neural system, which leads to limb tremors and difficulty in walking and other movements.China has 2 million patients suffering from Parkinson's disease, mostly people over the age of 50, and the number is increasing by 100,000 annually, said Dr. Wang.

CANBERRA, March 23 (Xinhua) -- Up to 45 native species in Western Australia's Kimberley region will die out within 20 years if no action is taken, latest study showed on Wednesday.The Priority Threat Management to Protect Kimberley Wildlife report, released by Commonwealth Scientific and Industrial Research Organization (CSIRO) on Wednesday, was commissioned by the Wilderness Society.The report showed that at present, 20.2 million U.S. dollars a year is spent on conservation efforts in the Kimberley, which is home to an assortment of threatened species.However, the report said even if that money was spent properly, the region would still lose some 31 native animals.The numbers of many more birds, reptiles and mammals, such as the Spotted Tree Monitor and the Western Chestnut Mouse, would dwindle.It called for an immediate cash injection of 96 million U.S. dollars to save creatures like the Golden Bandicoot, the Scaly- Tailed Possum and the Monjon Rock Wallaby from extinction.It will follow by an ongoing investment of 40.43 million U.S. dollars annually in the Kimberley to protect its species, as well as boost plant life, help the climate and conserve indigenous land."This investment is great value," one of the report's six co- authors Hugh Possingham said in a statement released on Wednesday."We can save some of Australia's most iconic mammals and birds at a cost of only about one million U.S. dollars per species per year."

CONAKRY, Feb. 14 (Xinhua) -- Guinean President Alpha Conde said Monday while meeting with visiting Chinese Foreign Minister Yang Jiechi that Guinea hopes to expand cooperation with China in a wide range of fields.Conde said Guinea values the traditional friendship with China, is grateful to China's assistance to Guinea under the framework of the Forum on China-Africa Cooperation, and appreciates the contribution China has made to the peace and common development of the world as well as the recovery of world economy from the global financial crisis.He reiterated Guinea's adherence to the one-China policy, and said the country is willing to learn from China's development experiences. Guinea hopes to further expand cooperation with China in such fields as water resources management, electricity generation and infrastructure building, said the president, who also welcomed Chinese companies to invest in Guinea.Also in a meeting with the visiting Chinese foreign minister, Guinea's Prime Minister Mohamed Said Fofana thanked China for sending medical teams to Guinea, helping Guinea train personnel in various sectors and constructing a series of aid projects in the African country. Fofana said Guinea expects to carry out all- around and mutually beneficial cooperation with China.For his part, the Chinese foreign minister said China-Guinea relations have been enjoying healthy and stable development throughout a period of over half a century, featuring political equality, mutual benefit and friendship.Yang said China has always been supporting Guinea's strive for peace and stability, and offering assistance for Guinea in social and economic development. He said enterprises from both sides have been carrying out cooperation in such realms as telecommunications, infrastructure building, among others.Yang said Guinea has successfully completed a political transition, and under the leadership of President Conde, the country will surely make more achievements in social and economic development. He noted that China is willing to make joint efforts with Guinea to consolidate traditional friendship, expand cooperation and push bilateral relations to a new height.The visiting foreign minister, who arrived here on Sunday, also met with his Guinean counterpart Edouard Niankoye Lama on Monday on bilateral cooperation and a number of other issues.

WASHINGTON, April 3 (Xinhua) -- In the largest study of its kind, researchers from a consortium led by the University of Pennsylvania School of Medicine, the University of Miami, and the Boston University School of Medicine, identified four new genes linked to Alzheimer's disease. The findings appeared Sunday in the current issue of Nature Genetics.Each gene individually adds to the risk of having this common form of dementia later in life. These new genes offer a portal into what causes Alzheimer's disease and is a major advance in the field.The study, conducted by the Alzheimer's Disease Genetics Consortium, reports genetic analysis of more than 11,000 people with Alzheimer's disease and a nearly equal number of elderly people who have no symptoms of dementia. Three other consortia contributed confirming data from additional people, bringing the total number of people analyzed to over 54,000. The consortium also contributed to the identification of a fifth gene reported by other groups of investigators from the United States, the United Kingdom, France, and other European countries.The study is the result of a large collaborative effort with investigators from 44 universities and research institutions in the United States, led by Gerard Schellenberg at University of Pennsylvania."This is the culmination of years of work on Alzheimer's disease by a large number of scientists, yet it is just the beginning in defining how genes influence memory and intellectual function as we age. We are all tremendously excited by our progress so far, but much remains to be done, both in understanding the genetics and in defining how these genes influence the disease process," Schellenberg said.Until recently, only four genes associated with late-onset Alzheimer's have been confirmed, with the gene for apolipoprotein E-e4, APOE-e4, having the largest effect on risk. The Nature Genetics studies add another four -- MS4A, CD2AP, CD33, and EPHA1 -- and contribute to identifying and confirming two other genes, BIN1 and ABCA7, thereby doubling the number of genes known to contribute Alzheimer's disease.